Educated Patient® Leukemia Summit

“We are fortunate now to live in an era where we have nine new drugs approved (for AML) just in the last five years,” says an expert from The University of Texas MD Anderson Cancer Center.

Treatment for acute lymphoblastic leukemia can be long and difficult at times, but the end goal is curing the disease.

Outcomes in patients with CLL continue to improve with the emergence of targeted drugs and immunotherapy.

How are myelodysplastic syndromes diagnosed and staged? What causes them? An expert from Moffit Cancer Center offers insight.

View the full CURE Educated Patient Leukemia Summit on demand.

Although CLL follows a different staging format than other cancer types, diagnosing the disease properly can open the doors for more effective treatment and management strategies.